Hypha Labs, Inc.
FUNI
$0.029
-$0.001-3.33%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1,748.87% | 518.45% | 1,009.58% | 1,368.03% | -34.20% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1,748.87% | 518.45% | 1,009.58% | 1,368.03% | -34.20% |
Operating Income | -1,748.87% | -518.45% | -1,009.58% | -1,368.03% | 34.20% |
Income Before Tax | -850.07% | -184.40% | -376.86% | 93.43% | 45.66% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -850.07% | -177.38% | -362.03% | 53.45% | 45.66% |
Earnings from Discontinued Operations | -- | -100.00% | -- | 438.67% | 1,423.96% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -983.64% | -278.48% | -340.85% | 449.33% | 163.09% |
EBIT | -1,748.87% | -518.45% | -1,009.58% | -1,368.03% | 34.20% |
EBITDA | -- | -1,556.44% | -14,507.14% | -- | -- |
EPS Basic | -735.29% | -230.00% | -288.57% | 425.00% | 158.62% |
Normalized Basic EPS | -560.00% | -125.00% | -236.36% | -388.89% | 37.50% |
EPS Diluted | -735.29% | -230.00% | -385.71% | 425.00% | 158.62% |
Normalized Diluted EPS | -560.00% | -125.00% | -236.36% | -388.89% | 37.50% |
Average Basic Shares Outstanding | 43.08% | 36.09% | 28.17% | 11.89% | 5.93% |
Average Diluted Shares Outstanding | 43.08% | 36.09% | 28.17% | 11.89% | 5.93% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |